Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques?
Authors:
Open Access
- 19 October 2020
- journal article
- research article
- Published by S. Karger AG in Breast Care
- Vol. 16 (4) , 358-367
Abstract
Introduction: The aim of the present study was to estimate the impact of the addition of internal mammary chain (IMC) irradiation in node-positive left-sided breast cancer (BC) patients undergoing regional nodal irradiation (RNI) and comparatively evaluate excess relative and absolute risks of radiation-induced lung cancer/BC and ischaemic heart disease for intensity-modulated radiotherapy (IMRT) versus 3D conformal radiotherapy (3D-CRT). Methods: Four treatment plans were created (3D-CRT and IMRT –/+ IMC) for each of the 10 evaluated patients, and estimates of excess relative risk (ERR) and 10-year excess absolute risk (EAR) were calculated for radiation-induced lung cancer/BC and coronary events using linear, linear-exponential and plateau models. Results: The addition of IMC irradiation to RNI significantly increased the dose exposure of the heart, lung and contralateral breast using both techniques, increasing ERR for secondary lung cancer (58 vs. 44%, p = 0.002), contralateral BC (49 vs. 31%, p = 0.002) and ischaemic heart disease (41 vs. 27%, p = 0.002, IMRT plans). IMRT significantly reduced the mean cardiac dose and mean lung dose as compared to 3D-CRT, decreasing ERR for major coronary events (64% 3D-CRT vs. 41% IMRT, p = 0.002) and ERR for secondary lung cancer (75 vs. 58%, p = 0.004) in IMC irradiation, without a significant impact on secondary contralateral BC risks. Conclusion: Although IMC irradiation has been shown to increase survival rates in node-positive BC patients, it increased dose exposure of organs at risk in left-sided BC, resulting in significantly increased risks for secondary lung cancer/contralateral BC and ischaemic heart disease. In this setting, the adoption of IMRT seems advantageous when compared to 3D-CRT.Keywords
This publication has 56 references indexed in Scilit:
- Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancerBritish Journal of Cancer, 2012
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31Journal of Clinical Oncology, 2011
- Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977–2001Radiotherapy and Oncology, 2011
- Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapyTheoretical Biology and Medical Modelling, 2011
- Development and Validation of a Heart Atlas to Study Cardiac Exposure to Radiation Following Treatment for Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Second malignancies after breast cancer: the impact of different treatment modalitiesBritish Journal of Cancer, 2008
- Effect of Breast Cancer Radiotherapy and Cigarette Smoking on Risk of Second Primary Lung CancerJournal of Clinical Oncology, 2008
- Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation TreatmentJournal of Clinical Oncology, 2006
- Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivorsCancer, 2003
- Adjuvant Radiotherapy and Risk of Contralateral Breast CancerJNCI: Journal of the National Cancer Institute, 1992